Prevalence of metabolic syndrome in scholars from Bucaramanga, Colombia: a population-based study

Cristina Villa-Roel1, Adriana Buitrago, Diana C Rodríguez

  • 1Pediatric Research Area, Fundación Cardiovascular de Colombia, Floridablanca, Calle 155 A # 23 - 58, Urbanización el Bosque/Floridablanca/Santander, Colombia. Cristina.villaroel@capitalhealth.ca

BMC Pediatrics
|April 23, 2009
PubMed

Insights

This study investigated metabolic syndrome in Colombian children, highlighting the need for preventive strategies. Understanding risk factors is crucial for early intervention against cardio-metabolic diseases in developing nations.

Area of Science:

  • Pediatrics
  • Public Health
  • Epidemiology

Background:

  • Obesity and metabolic syndrome prevalence is rising in children globally, particularly in developing countries.
  • These conditions are linked to type 2 diabetes mellitus and cardiovascular diseases.
  • Understanding their epidemiology and determinants in children is crucial.

Purpose of the Study:

  • To determine the prevalence of metabolic syndrome in 6-10 year-old children in Bucaramanga, Colombia.
  • To characterize socio-demographic, nutritional, and physical activity factors.
  • To analyze the association between metabolic syndrome components and insulin resistance.

Main Methods:

  • Cross-sectional study utilizing a two-stage random-cluster sampling method.
  • Domiciliary surveys for socio-demographic, nutritional, and physical activity data.
  • Clinical examinations including anthropometry, blood pressure, lipid profiles, glucose, and insulin levels.

Main Results:

  • Prevalence of metabolic syndrome determined using specific percentile cut-off points for the population.
  • Analysis of associations between metabolic syndrome components and insulin resistance via multivariable logistic regression.

Conclusions:

  • Findings will inform policy makers, healthcare providers, and educators on preventive initiatives.
  • Provides insight into pathophysiological mechanisms of early-life cardio-metabolic disease development.
  • Essential for guiding primary and secondary prevention strategies in similar settings.
Abstract

Related Concept Videos

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Bias in Epidemiological Studies01:29

Bias in Epidemiological Studies

Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:
Overview of Carbohydrate Metabolism01:19

Overview of Carbohydrate Metabolism

Carbohydrate metabolism is a fundamental biochemical process that ensures a constant supply of energy to living cells. The most important carbohydrate is glucose, which can be broken down via glycolysis to enter into the Krebs cycle and eventually lead to the production of ATP through oxidative phosphorylation.
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Prevalence and Incidence01:08

Prevalence and Incidence

In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health condition at a...